• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TPA 治疗≥80 岁缺血性脑卒中患者。

TPA for ischemic stroke in patients ≥80 years.

机构信息

Department of Neurology, Sørlandet Hospital, Kristiansand, Norway.

出版信息

Acta Neurol Scand. 2013 May;127(5):309-15. doi: 10.1111/ane.12008. Epub 2012 Sep 18.

DOI:10.1111/ane.12008
PMID:22988960
Abstract

OBJECTIVE

Although patients >80 years were excluded in RCTs for tPA treatment of acute ischemic stroke (AIS), many centers treat old patients. We wanted to examine whether age ≥80 years is an independent predictor of outcome after tPA.

MATERIALS

We included 77 consecutive patients ≥80 years and 83 patients <80 years treated with tPA within 4.5 h after onset of AIS. Baseline variables were analyzed by multiple stepwise logistic regression analyses against three outcomes: symptomatic intracerebral hemorrhage (sICH), death and good functional outcome (mRS, 0-1) at 3-month follow-up.

RESULTS

Age ≥80 years was associated with increased risk of sICH (OR, 18.2 [95% CI, 1.0-324.1], P = 0.048), and death (OR, 3.3 [95% CI, 1.2-9.1], P = 0.018), but not with functional outcome at 3 months. Other factors associated with death were longer onset to treatment time (OTT) (OR, 1.007/min increase [95% CI, 1.00-1.015], P = 0.047), higher NIHSS (OR, 1.12 per point increase [95% CI, 1.04-1.19], P = 0.001), and previous stroke (OR, 4.0 [95% CI, 1.2-13.7], P = 0.03). Predictors of good functional outcome were shorter OTT (OR, 0.99 [95% CI, 0.98-1.00], P = 0.02) and lower NIHSS (OR, 0.80 [95% CI, 0.74-0.87] P ≤ 0.001).

CONCLUSION

Age ≥80 years might be an independent risk factor for sICH and death the first 3 months after treatment with tPA for AIS, but does not influence the chance of a good functional outcome. We suggest to treat patients over 80 years with tPA, but be cautious if the time from onset (OTT) is long.

摘要

目的

尽管急性缺血性脑卒中(AIS)的 tPA 治疗 RCT 排除了 80 岁以上的患者,但许多中心仍治疗老年患者。我们希望研究年龄≥80 岁是否是 tPA 治疗 AIS 后结局的独立预测因素。

材料

我们纳入了 77 例连续的≥80 岁和 83 例<80 岁的 AIS 发病后 4.5 小时内接受 tPA 治疗的患者。通过多步逻辑回归分析,针对三种结局(症状性颅内出血[sICH]、死亡和 3 个月随访时的良好功能结局[mRS,0-1])对基线变量进行分析。

结果

年龄≥80 岁与 sICH 风险增加相关(OR,18.2[95%CI,1.0-324.1],P=0.048)和死亡(OR,3.3[95%CI,1.2-9.1],P=0.018)相关,但与 3 个月时的功能结局无关。其他与死亡相关的因素包括发病至治疗时间(OTT)延长(OR,每增加 1 分钟 1.007[95%CI,1.00-1.015],P=0.047)、NIHSS 评分升高(OR,每增加 1 分 1.12[95%CI,1.04-1.19],P=0.001)和既往卒中(OR,4.0[95%CI,1.2-13.7],P=0.03)。良好功能结局的预测因素是 OTT 缩短(OR,0.99[95%CI,0.98-1.00],P=0.02)和 NIHSS 评分降低(OR,0.80[95%CI,0.74-0.87],P≤0.001)。

结论

年龄≥80 岁可能是 AIS 接受 tPA 治疗后 3 个月内 sICH 和死亡的独立危险因素,但不影响良好功能结局的机会。我们建议对 80 岁以上的患者使用 tPA 治疗,但如果发病时间(OTT)较长,应谨慎。

相似文献

1
TPA for ischemic stroke in patients ≥80 years.TPA 治疗≥80 岁缺血性脑卒中患者。
Acta Neurol Scand. 2013 May;127(5):309-15. doi: 10.1111/ane.12008. Epub 2012 Sep 18.
2
Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.重组组织型纤溶酶原激活剂溶栓治疗急性缺血性脑卒中后院内死亡率及症状性颅内出血的风险预测因素。
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11.
3
Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.静脉注射 rt-PA 治疗卒中患者后 24 小时内的早期神经功能恶化:卒中急性管理伴紧急风险因素评估和 rt-PA 改善登记研究。
Cerebrovasc Dis. 2012;34(2):140-6. doi: 10.1159/000339759. Epub 2012 Aug 1.
4
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.症状性颅内出血:急性缺血性脑卒中静脉溶栓治疗后之关键回顾。
Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1.
5
Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?阿司匹林和氯吡格雷联合抗血小板治疗:急性缺血性卒中溶栓相关脑出血的危险因素?
J Neurol Sci. 2009 Sep 15;284(1-2):155-7. doi: 10.1016/j.jns.2009.05.003. Epub 2009 May 26.
6
Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.肾功能损害降低急性缺血性脑卒中溶栓治疗的疗效。
Cerebrovasc Dis. 2013;35(1):45-52. doi: 10.1159/000345071. Epub 2013 Feb 14.
7
The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.颅内颈动脉硬化对溶栓后引起的脑出血的影响。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e455-62. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.008. Epub 2013 Jun 22.
8
Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.溶栓治疗对曾接受抗凝治疗的脑卒中患者的安全性和结局。
Cerebrovasc Dis. 2012;33(3):231-9. doi: 10.1159/000334662. Epub 2012 Jan 19.
9
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.急性卒中中组织型纤溶酶原激活剂治疗与早期基质金属蛋白酶-9升高之间的关联。
Neurology. 2006 May 23;66(10):1550-5. doi: 10.1212/01.wnl.0000216133.98416.b4.
10
Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.日本 4 家医院组织中的组织型纤溶酶原激活物溶栓治疗急性缺血性脑卒中。
J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

引用本文的文献

1
Predictors and long-term outcome of intracranial hemorrhage after thrombolytic therapy for acute ischemic stroke-A prospective single-center study.急性缺血性卒中溶栓治疗后颅内出血的预测因素及长期预后——一项前瞻性单中心研究
Front Neurol. 2023 Feb 1;14:1080046. doi: 10.3389/fneur.2023.1080046. eCollection 2023.
2
Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?为何不在3个月内复发性卒中患者中进行静脉溶栓治疗?
Aging Dis. 2018 Apr 1;9(2):309-316. doi: 10.14336/AD.2017.0406. eCollection 2018 Apr.
3
Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
接受溶栓治疗的急性缺血性卒中患者院内死亡和有症状颅内出血的预测因素:保罗·科弗代尔急性卒中登记研究(2008 - 2012年)
Int J Stroke. 2014 Aug;9(6):728-34. doi: 10.1111/ijs.12155. Epub 2013 Sep 12.
4
Effectiveness of alteplase in the very elderly after acute ischemic stroke.急性缺血性脑卒中后高龄患者使用阿替普酶的效果。
Clin Interv Aging. 2013;8:963-74. doi: 10.2147/CIA.S48269. Epub 2013 Jul 24.